Darian Overcomes Aortic Stenosis & Healthcare Inequity Thanks to Medtronic TAVR
Written By: Adam Pick, Patient Advocate & Author
Medical Expert: Mustafa Ahmed, MD, Interventional Cardiologist, UAB Medicine
Published: October 18, 2022
Aortic stenosis is a life-threatening disease that is under-diagnosed and under-treated. In fact, the survival rate is just 50% at two years for patients diagnosed with symptomatic severe aortic stenosis. To make matters worse, only 9% of patients that receive non-invasive transcatheter aortic valve replacement (TAVR) are minorities according to this research.
How is Medtronic, a leading TAVR manufacturer, changing this healthcare inequity to help aortic stenosis patients like Mrs. Darian Tymes? Watch this video to find out.
Many Thanks to Darian, Dr. Ahmed and Medtronic!
Many thanks to Darian and Dr. Mustafa Ahmed for sharing their wonderful story with our community!
A special thanks goes out to Medtronic for their commitment to removing barriers that prevent patients from life-saving procedures for aortic stenosis. We are so appreciative of Medtronic’s dedication to advancing valvular therapy and Medtronic’s initiatives to expand treatment for minorities.
To learn more, please visit MyInteractiveASJourney.com.
Keep on tickin’ Darian!
Adam
Written by Adam Pick
- Patient & Website Founder
